These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 1613515)
1. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. Spina MB; Squinto SP; Miller J; Lindsay RM; Hyman C J Neurochem; 1992 Jul; 59(1):99-106. PubMed ID: 1613515 [TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor protects dopaminergic cells from 6-hydroxydopamine toxicity. Spina MB; Hyman C; Squinto S; Lindsay RM Ann N Y Acad Sci; 1992 May; 648():348-50. PubMed ID: 1637069 [No Abstract] [Full Text] [Related]
3. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Offen D; Sherki Y; Melamed E; Fridkin M; Brenneman DE; Gozes I Brain Res; 2000 Jan; 854(1-2):257-62. PubMed ID: 10784133 [TBL] [Abstract][Full Text] [Related]
4. Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons. Pong K; Doctrow SR; Baudry M Brain Res; 2000 Oct; 881(2):182-9. PubMed ID: 11036157 [TBL] [Abstract][Full Text] [Related]
6. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone. Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799 [TBL] [Abstract][Full Text] [Related]
7. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. Hyman C; Juhasz M; Jackson C; Wright P; Ip NY; Lindsay RM J Neurosci; 1994 Jan; 14(1):335-47. PubMed ID: 8283241 [TBL] [Abstract][Full Text] [Related]
8. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system. Hou JG; Cohen G; Mytilineou C J Neurochem; 1997 Jul; 69(1):76-83. PubMed ID: 9202296 [TBL] [Abstract][Full Text] [Related]
9. Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro. Kramer BC; Goldman AD; Mytilineou C Brain Res; 1999 Dec; 851(1-2):221-7. PubMed ID: 10642847 [TBL] [Abstract][Full Text] [Related]
10. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. Hou JG; Lin LF; Mytilineou C J Neurochem; 1996 Jan; 66(1):74-82. PubMed ID: 8522992 [TBL] [Abstract][Full Text] [Related]
11. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment. Zhou J; Bradford HF; Stern GM Brain Res; 1994 Sep; 656(1):147-56. PubMed ID: 7804829 [TBL] [Abstract][Full Text] [Related]
12. Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. von Coelln R; Kügler S; Bähr M; Weller M; Dichgans J; Schulz JB J Neurochem; 2001 Apr; 77(1):263-73. PubMed ID: 11279282 [TBL] [Abstract][Full Text] [Related]
13. Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins. Sabolek M; Mieskes I; Lenk T; Lehmensiek V; Hermann A; Schwarz J; Storch A Neurotoxicology; 2008 Jul; 29(4):714-21. PubMed ID: 18513801 [TBL] [Abstract][Full Text] [Related]
14. Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon. Spenger C; Hyman C; Studer L; Egli M; Evtouchenko L; Jackson C; Dahl-Jørgensen A; Lindsay RM; Seiler RW Exp Neurol; 1995 May; 133(1):50-63. PubMed ID: 7601263 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture. Callier S; Le Saux M; Lhiaubet AM; Di Paolo T; Rostène W; Pelaprat D J Neurochem; 2002 Jan; 80(2):307-16. PubMed ID: 11902121 [TBL] [Abstract][Full Text] [Related]
16. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Frim DM; Uhler TA; Galpern WR; Beal MF; Breakefield XO; Isacson O Proc Natl Acad Sci U S A; 1994 May; 91(11):5104-8. PubMed ID: 8197193 [TBL] [Abstract][Full Text] [Related]
18. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease. Stahl K; Mylonakou MN; Skare Ø; Amiry-Moghaddam M; Torp R Brain Res; 2011 Mar; 1378():105-18. PubMed ID: 21236244 [TBL] [Abstract][Full Text] [Related]
19. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures. Ostergaard K; Jones SA; Hyman C; Zimmer J Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. Altar CA; Boylan CB; Fritsche M; Jones BE; Jackson C; Wiegand SJ; Lindsay RM; Hyman C J Neurochem; 1994 Sep; 63(3):1021-32. PubMed ID: 7519657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]